McClellan William D. Jr.
Director at REATA PHARMACEUTICALS INC
- Sold, on record
- $2.1M
- Dollars the filings state
- Form 4 sales
- 3
- Latest Jul 28, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REATA PHARMACEUTICALS INCDirector
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale REATA PHARMACEUTICALS INCUnusualNov 9, 2020 2020
Sold 4,000 shares at $150.01 ($600k)
McClellan William D. Jr., Director
Sold 100% of holdings ($600k position)0 shares leftFirst sale on recordFiling
- 2 Form 4 sale REATA PHARMACEUTICALS INCUnusualNov 12, 2020 +3 days
Sold 4,000 shares at $172.92 ($692k)
McClellan William D. Jr., Director
Sold 100% of holdings ($692k position)0 shares leftFiling
- 3 Form 144 notice REATA PHARMACEUTICALS INCNoticeJul 28, 2023 +988 days
Filed to sell 5,000 shares ($822k)
McClellan William D. Jr., Director
10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale REATA PHARMACEUTICALS INCRoutineJul 28, 2023 same day
Sold 5,000 shares at $164.49 ($822k)
McClellan William D. Jr., Director
10b5-1 planSold 45.4% of holdings ($1.8M position)6,017 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 28, 2023 | Aug 1, 2023 | REATA PHARMACEUTICALS INC | Director | Form 4 sale | 5,000 | $822k | 45.4% | Routine | SEC |
| Jul 28, 2023 | Jul 28, 2023 | REATA PHARMACEUTICALS INC | Director | Form 144 notice | 5,000 | $822k | Notice | SEC | |
| Nov 12, 2020 | Nov 13, 2020 | REATA PHARMACEUTICALS INC | Director | Form 4 sale | 4,000 | $692k | 100.0% | Unusual | SEC |
| Nov 9, 2020 | Nov 10, 2020 | REATA PHARMACEUTICALS INC | Director | Form 4 sale | 4,000 | $600k | 100.0% | Unusual | SEC |